دوره 10، شماره 1 - ( 12-1402 )
جلد 10 شماره 1 : e11 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Massoodi A, Dehbozorgi S, Nekouei Shoja N, Zavarmousavi S M. Comparison of Risperidone and Aripiprazole in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review. CJP 2024; 10 (1)
URL: http://caspianjp.ir/article-1-205-fa.html
URL: http://caspianjp.ir/article-1-205-fa.html
Comparison of Risperidone and Aripiprazole in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review. مجله کاسپین کودکان. 1402; 10 (1)
چکیده: (553 مشاهده)
Background and Objective: Attention-deficit/hyperactivity disorder (ADHD) is a disorder of childhood and adolescence characterized by persistent symptoms of increased activity and impulsive behavior. Totally, 2-5% of schoolchildren exhibit specific and comprehensive symptoms of ADHD. The aim of the present study was to investigate the comparison of risperidone and aripiprazole in the treatment of ADHD children.
Methods: A literature search was performed in the electronic databases of Embase, PubMed, Web of Science, Scopus, and Google Scholar for articles published from inception between 2005 and 2022. Persian keywords and their English equivalents in Mesh were used to search all domestic and foreign articles in all databases. This systematic review was conducted according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines and the quality of articles was assessed using the risk of bias checklist.
Findings: Of the 320 articles initially identified, 8 were eventually included, with 4 articles published from Iran and 4 articles from other countries. Totally, 50% of the studies were related to Iran. The age of the studied subjects ranged from 3 to 18 years, and 283 children were studied and investigated. In 90% of the studies, with p>0.05, there was no significant difference in the efficacy of the two drugs, risperidone and aripiprazole.
Conclusion: In general, both risperidone and aripiprazole are effective for the treatment of ADHD and can be used according to the clinical conditions and medical history of the child.
Methods: A literature search was performed in the electronic databases of Embase, PubMed, Web of Science, Scopus, and Google Scholar for articles published from inception between 2005 and 2022. Persian keywords and their English equivalents in Mesh were used to search all domestic and foreign articles in all databases. This systematic review was conducted according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines and the quality of articles was assessed using the risk of bias checklist.
Findings: Of the 320 articles initially identified, 8 were eventually included, with 4 articles published from Iran and 4 articles from other countries. Totally, 50% of the studies were related to Iran. The age of the studied subjects ranged from 3 to 18 years, and 283 children were studied and investigated. In 90% of the studies, with p>0.05, there was no significant difference in the efficacy of the two drugs, risperidone and aripiprazole.
Conclusion: In general, both risperidone and aripiprazole are effective for the treatment of ADHD and can be used according to the clinical conditions and medical history of the child.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
